Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree

被引:44
作者
Connelly, PW
Hanley, AJ
Harris, SB
Hegele, RA
Zinman, B
机构
[1] St Michaels Hosp, J Alick Little Lipid Res Lab, Toronto, ON M5B 1A6, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] Univ Toronto, Dept Biochem, Toronto, ON, Canada
[5] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[6] Univ Western Ontario, Ctr Studies Family Med, London, ON, Canada
[7] Robarts Res Inst, London, ON N6A 5C1, Canada
关键词
C-reactive protein; diabetes; aboriginal; vitamin B6; waist; body mass index;
D O I
10.1038/sj.ijo.0802239
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To determine the prevalence of elevated C-reactive protein (CRP) in the Sandy Lake Oji-Cree, an aboriginal community residing in the Sioux Lookout zone of Northwestern Ontario, Canada, and to determine the associations of obesity and diabetes with CRP in a community with a very high prevalence of type II diabetes. DESIGN: We surveyed 512 community members aged 18y and older to determine the prevalence and the determinants of elevated CRP in Sandy Lake. MEASUREMENTS: Clinical variables, indices of obesity and serum concentrations of CRP, insulin, serum amyloid A (SAA) and interleukin-6 (IL-6). RESULTS: The prevalence of CRP greater than or equal to3.8mg/l was significantly higher in women than in men (51% vs. 32%, P<0.0001). Regression analysis determined that body mass index and IL-6 were independent determinants of CRP concentration in women and waist circumference and IL-6 were independent determinants of CRP concentration in men. Diabetes was associated with elevated CRP in both sexes, but was only a moderate strong determinant in CRP concentration in multivariate regression analysis. CONCLUSIONS: The prevalence of elevated CRP in this aboriginal community is remarkably high. These data further demonstrate that the association between CRP and specific indices of obesity and metabolism vary according to gender and glycemic status.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 33 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]   High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis [J].
Blake, GJ ;
Ridker, PM .
EUROPEAN HEART JOURNAL, 2001, 22 (05) :349-352
[3]   Human C-reactive protein (CRP) 1059G/C polymorphism [J].
Cao, HN ;
Hegele, RA .
JOURNAL OF HUMAN GENETICS, 2000, 45 (02) :100-101
[4]   The role of complement and complement receptors in induction and regulation of immunity [J].
Carroll, MC .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :545-568
[5]   Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA [J].
Circolo, A ;
Garnier, G ;
Fukuda, W ;
Wang, XF ;
Hidvegi, T ;
Szalai, AJ ;
Briles, DE ;
Volanakis, JE ;
Wetsel, RA ;
Colten, HR .
IMMUNOPHARMACOLOGY, 1999, 42 (1-3) :135-149
[6]   Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Gallimore, JR ;
Pepys, MB .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204
[7]   Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
CIRCULATION, 2000, 102 (01) :42-47
[8]   Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins - The atherosclerosis risk in communities (ARIC) study [J].
Folsom, AR ;
Nieto, FJ ;
McGovern, PG ;
Tsai, MY ;
Malinow, MR ;
Eckfeldt, JH ;
Hess, DL ;
Davis, CE .
CIRCULATION, 1998, 98 (03) :204-210
[9]  
Friso S, 2001, CIRCULATION, V103, P2788
[10]  
Gavin JR, 1997, DIABETES CARE, V20, P1183